Due to rising reports of fraudulent, tainted, or unsafe shipments of semaglutide and tirzepatide entering the U.S., the FDA has created a green list of API manufacturers whose facilities meet its safety standards
Thornton K, and Gorenstein DG
Its not always easy to distinguish between the two based on symptoms alone, especially in someone with active disease, she says
At AZ IV Medics, we ensure all treatments are conducted in a sterile environment under medical supervision
Common side effects include nausea, vomiting, diarrhea, constipation, stomach discomfort, and decreased appetite